Factors determining the risk of severe (WHO grades 3 and 4) hemorrhage in hematologic patients

Transfusion and Apheresis Science

Volumn 44, Issue 2, 2011, Pages 129-134

  Drozd Sokolowska, Joanna Ewa ^a   Wiktor Jedrzejczak, Wieslaw ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLEEDING; DISEASE SEVERITY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POLAND; RISK FACTOR; SEX DIFFERENCE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEMORRHAGE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; PLATELET TRANSFUSION; POLAND; RISK; THROMBOCYTOPENIA; WORLD HEALTH ORGANIZATION;

EID: 79952628557     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2011.01.004     Document Type: Article

References (27)

1. Gaydos L.A., Freireich E.J., Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med 1962, 266:905-909.
2. Han T., Stutzman L., Cohen E., Kim U. Effect of platelet transfusion on hemorrhage in patients with acute leukemia. Cancer 1966, 19:1937-1942.
3. Higby D.J., Cohen E., Holland J.F., Sinks L. The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study. Transfusion 1974, 14(5):440-446.
4. Rebulla P., Finazzi G., Marangoni F., Avvisati G., Gugliotta L., Tognoni G., et al. For the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto: the threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N Engl J Med 1997, 337:1870-1875.
5. Wandt H., Frank M., Ehninger G., Schneider Ch., Brack N., Daoud A., et al. Safety and cost effectiveness of a 10×109/L trigger for prophylactic platelet transfusions compared with the traditional 20×109/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 1998, 91:3601-3606.
6. Lawrence J.B., Yomtovian R.A., Hammons T., Masarik S.R., Chongkolwatana V., Creger R.J., et al. Lowering the prophylactic platelet transfusion threshold: a prospective analysis. Leuk Lymphoma 2001, 41:67-76.
7. Gmür J., Burger J., Schanz U., Fehr J., Schaffner A. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukemia. Lancet 1991, 338:1223-1226.
8. Gil-Fernandez J.J., Alegre A., Fernandez-Villata M.J. Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution. Bone Marrow Transplant 1996, 18:931-935.
9. Heckman K.D., Weiner G.J., Davis C.S. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/μl versus 20,000/μl. J Clin Oncol 1997, 15:1143-1149.
10. Navarro J.T., Hernandez J.A., Ribera J.M. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/μl versus 20,000/μl. Haematologica 1998, 83:998-1000.
11. Diedrich B., Remberger M., Shanwell A., Svahn B.M., Ringden O. A prospective randomized trial of a prophylactic platelet transfusion trigger of 10×10(9) per L versus 30×10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients. Transfusion 2005, 45:1064-1072.
12. Slichter S.J. Relationship between platelet count and bleeding risk in thrombocytopenic patients. Transfus Med Rev 2004, 18:153-167.
13. Heddle N.M., Cook R.J., Webert K.E., Sigouin C., Rebulla P. Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies. Transfusion 2003, 43:742-752. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society for Blood Transfusion.
14. Nevo S., Fuller A.K., Hartley E., Borinsky M.E., Vogelsang G.B. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10×10(9) and 20×10(9) per L. Transfusion 2007, 47:801-812.
15. Greeno E., McCulloough J., Weisdorf D. Platelet utilization and the transfusion trigger: a prospective analysis. Transfusion 2007, 47:201-205.
16. Roy A., Jaffe N., Djerassi I. Prophylactic platelet transfusion in children with acute leukemia: a dose response study. Transfusion 1973, 13:283-290.
17. Klumpp T.R., Herman J.H., Gaughan J.P., et al. Clinical cosequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial. Transfusion 1999, 39:674-681.
18. Tinmouth A.T., Freedman J. Prophylactic platelet transfusions: which dose is the best dose? A review of literature. Transfus Med Rev 2003, 17:181-193.
19. Ackerman S.J., Klumpp T.R., Guzman G.I., Herman J.H., Gaughan J.P., Bleecker G.C., et al. Economic consequences of alterations in platelet transfusion dose: analysis of a prospective, randomized, double-blind trial. Transfusion 2000, 40:1457-1462.
20. Slichter S.J. Evidence-based platelet transfusion guidelines. Hematology Am Soc Hematol Educ Program 2007, 172-178.
21. Schiffer C.A., Anderson K.C., Bennett C.L., Bernstein S., Elting L., Goldsmith M., et al. Platelet transfusions for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001, 19:1519-1538.
22. Stanworth S.J., Hyde C., Brunskill S., Murphy M.F. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?. Br J Haematol 2005, 588-595.
23. Tinmouth A., Tannock I.F., Crump M., Tomlinson G., Brandwein J., Minden M., et al. Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized, controlled trial with a sequential Bayesian design. Transfusion 2004, 44:1711-1719.
24. Cid J., Lozano M. Lower or higher doses for prophylactic platelet transfusions: results of a meta-analysis od randomized controlled trials. Transfusion 2007, 47:464-470.
25. Strauss G. Pretransfusion trigger platelet counts and dose for prophylactic platelet transfusions. Curr Opin Hematol 2005, 12:499-502.
26. Friedmann A.M., Sengul H., Lehmann H., Schwartz C., Goodman S. Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. Transfus Med Rev 2002, 16:34-45.
27. Stanworth S.J., Hyde C., Heddle N., Rebulla P., Brunskill S., Murphy M.F. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev 2004, 18:CD004269.